Ethical considerations related to the provision of care and treatment in vaccine trials

D. Tarantola, R. Macklin, Z. H. Reed, M. P. Kieny, S. Osmanov, M. Stobie, C. Hankins

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Ethical principles of beneficence and justice combined with international human rights norms and standards create certain obligations on researchers, sponsors and public health authorities. These include treatment provision for participants enrolled in clinical trials of vaccines, drugs and other new preventive and curative technologies and methods. However, these obligations are poorly defined in practical terms, inconsistently understood or inadequately applied. Vaccine clinical trial designs normally define standards of prevention applicable to the population where the trial is to take place. The present document addresses specifically the setting of standards applicable to care and treatment in vaccine trials. The lack of clear guidance on how to achieve the optimal synergy between the development of new health technologies, on the one hand, and the promotion and protection of ethical and human rights principles, on the other, is a barrier to the progress of health research and therefore to the advancement of public health. The World Health Organization and UNAIDS have engaged in a series of consultations in Africa, the Americas, Asia and Europe to reflect on how this aim could best be achieved. This document highlights the outcome of these consultations. It proposes a structured approach to consensual decision making in the context of the clinical trial of vaccines against such public health challenges as HIV and newly emerging or threatening epidemics. A structured approach involving investigators and sponsors in a consultative process with trial communities and other stakeholders in research will ensure that the needs and legitimate expectations of trial participants are appropriately met, obligations towards them are delivered and, as a result, ethical research is facilitated in the interest of public health.

Original languageEnglish (US)
Pages (from-to)4863-4874
Number of pages12
JournalVaccine
Volume25
Issue number26
DOIs
StatePublished - Jun 21 2007

Fingerprint

public health
Vaccines
Public Health
vaccines
human rights
clinical trials
Clinical Trials
Referral and Consultation
Research
Research Personnel
Beneficence
Biomedical Technology
Social Justice
World Health Organization
stakeholders
decision making
Decision Making
researchers
HIV
Technology

Keywords

  • Access to care
  • Best research practice
  • Clinical trials
  • Community consultation
  • Ethics
  • HIV
  • HIV care and treatment
  • HIV vaccines
  • Human rights
  • Standard of care
  • Standard setting
  • Treatment for trial participants
  • Vaccine trials

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Tarantola, D., Macklin, R., Reed, Z. H., Kieny, M. P., Osmanov, S., Stobie, M., & Hankins, C. (2007). Ethical considerations related to the provision of care and treatment in vaccine trials. Vaccine, 25(26), 4863-4874. https://doi.org/10.1016/j.vaccine.2007.03.022

Ethical considerations related to the provision of care and treatment in vaccine trials. / Tarantola, D.; Macklin, R.; Reed, Z. H.; Kieny, M. P.; Osmanov, S.; Stobie, M.; Hankins, C.

In: Vaccine, Vol. 25, No. 26, 21.06.2007, p. 4863-4874.

Research output: Contribution to journalArticle

Tarantola, D, Macklin, R, Reed, ZH, Kieny, MP, Osmanov, S, Stobie, M & Hankins, C 2007, 'Ethical considerations related to the provision of care and treatment in vaccine trials', Vaccine, vol. 25, no. 26, pp. 4863-4874. https://doi.org/10.1016/j.vaccine.2007.03.022
Tarantola D, Macklin R, Reed ZH, Kieny MP, Osmanov S, Stobie M et al. Ethical considerations related to the provision of care and treatment in vaccine trials. Vaccine. 2007 Jun 21;25(26):4863-4874. https://doi.org/10.1016/j.vaccine.2007.03.022
Tarantola, D. ; Macklin, R. ; Reed, Z. H. ; Kieny, M. P. ; Osmanov, S. ; Stobie, M. ; Hankins, C. / Ethical considerations related to the provision of care and treatment in vaccine trials. In: Vaccine. 2007 ; Vol. 25, No. 26. pp. 4863-4874.
@article{bc4faa7fc927405dadd60128c9c9ce09,
title = "Ethical considerations related to the provision of care and treatment in vaccine trials",
abstract = "Ethical principles of beneficence and justice combined with international human rights norms and standards create certain obligations on researchers, sponsors and public health authorities. These include treatment provision for participants enrolled in clinical trials of vaccines, drugs and other new preventive and curative technologies and methods. However, these obligations are poorly defined in practical terms, inconsistently understood or inadequately applied. Vaccine clinical trial designs normally define standards of prevention applicable to the population where the trial is to take place. The present document addresses specifically the setting of standards applicable to care and treatment in vaccine trials. The lack of clear guidance on how to achieve the optimal synergy between the development of new health technologies, on the one hand, and the promotion and protection of ethical and human rights principles, on the other, is a barrier to the progress of health research and therefore to the advancement of public health. The World Health Organization and UNAIDS have engaged in a series of consultations in Africa, the Americas, Asia and Europe to reflect on how this aim could best be achieved. This document highlights the outcome of these consultations. It proposes a structured approach to consensual decision making in the context of the clinical trial of vaccines against such public health challenges as HIV and newly emerging or threatening epidemics. A structured approach involving investigators and sponsors in a consultative process with trial communities and other stakeholders in research will ensure that the needs and legitimate expectations of trial participants are appropriately met, obligations towards them are delivered and, as a result, ethical research is facilitated in the interest of public health.",
keywords = "Access to care, Best research practice, Clinical trials, Community consultation, Ethics, HIV, HIV care and treatment, HIV vaccines, Human rights, Standard of care, Standard setting, Treatment for trial participants, Vaccine trials",
author = "D. Tarantola and R. Macklin and Reed, {Z. H.} and Kieny, {M. P.} and S. Osmanov and M. Stobie and C. Hankins",
year = "2007",
month = "6",
day = "21",
doi = "10.1016/j.vaccine.2007.03.022",
language = "English (US)",
volume = "25",
pages = "4863--4874",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "26",

}

TY - JOUR

T1 - Ethical considerations related to the provision of care and treatment in vaccine trials

AU - Tarantola, D.

AU - Macklin, R.

AU - Reed, Z. H.

AU - Kieny, M. P.

AU - Osmanov, S.

AU - Stobie, M.

AU - Hankins, C.

PY - 2007/6/21

Y1 - 2007/6/21

N2 - Ethical principles of beneficence and justice combined with international human rights norms and standards create certain obligations on researchers, sponsors and public health authorities. These include treatment provision for participants enrolled in clinical trials of vaccines, drugs and other new preventive and curative technologies and methods. However, these obligations are poorly defined in practical terms, inconsistently understood or inadequately applied. Vaccine clinical trial designs normally define standards of prevention applicable to the population where the trial is to take place. The present document addresses specifically the setting of standards applicable to care and treatment in vaccine trials. The lack of clear guidance on how to achieve the optimal synergy between the development of new health technologies, on the one hand, and the promotion and protection of ethical and human rights principles, on the other, is a barrier to the progress of health research and therefore to the advancement of public health. The World Health Organization and UNAIDS have engaged in a series of consultations in Africa, the Americas, Asia and Europe to reflect on how this aim could best be achieved. This document highlights the outcome of these consultations. It proposes a structured approach to consensual decision making in the context of the clinical trial of vaccines against such public health challenges as HIV and newly emerging or threatening epidemics. A structured approach involving investigators and sponsors in a consultative process with trial communities and other stakeholders in research will ensure that the needs and legitimate expectations of trial participants are appropriately met, obligations towards them are delivered and, as a result, ethical research is facilitated in the interest of public health.

AB - Ethical principles of beneficence and justice combined with international human rights norms and standards create certain obligations on researchers, sponsors and public health authorities. These include treatment provision for participants enrolled in clinical trials of vaccines, drugs and other new preventive and curative technologies and methods. However, these obligations are poorly defined in practical terms, inconsistently understood or inadequately applied. Vaccine clinical trial designs normally define standards of prevention applicable to the population where the trial is to take place. The present document addresses specifically the setting of standards applicable to care and treatment in vaccine trials. The lack of clear guidance on how to achieve the optimal synergy between the development of new health technologies, on the one hand, and the promotion and protection of ethical and human rights principles, on the other, is a barrier to the progress of health research and therefore to the advancement of public health. The World Health Organization and UNAIDS have engaged in a series of consultations in Africa, the Americas, Asia and Europe to reflect on how this aim could best be achieved. This document highlights the outcome of these consultations. It proposes a structured approach to consensual decision making in the context of the clinical trial of vaccines against such public health challenges as HIV and newly emerging or threatening epidemics. A structured approach involving investigators and sponsors in a consultative process with trial communities and other stakeholders in research will ensure that the needs and legitimate expectations of trial participants are appropriately met, obligations towards them are delivered and, as a result, ethical research is facilitated in the interest of public health.

KW - Access to care

KW - Best research practice

KW - Clinical trials

KW - Community consultation

KW - Ethics

KW - HIV

KW - HIV care and treatment

KW - HIV vaccines

KW - Human rights

KW - Standard of care

KW - Standard setting

KW - Treatment for trial participants

KW - Vaccine trials

UR - http://www.scopus.com/inward/record.url?scp=34249779551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249779551&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.03.022

DO - 10.1016/j.vaccine.2007.03.022

M3 - Article

VL - 25

SP - 4863

EP - 4874

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 26

ER -